The Middle East cancer targeted therapy market is witnessing substantial growth due to the increasing prevalence of cancer and the growing adoption of precision medicine across healthcare systems in the region. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9%...